Scott Barrett - Aug 3, 2021 Form 4 Insider Report for Immuneering Corp (IMRX)

Role: Chief Medical Officer
Signature: By: /s/ Michael D. Bookman, Attorney-in-Fact for Scott Barrett
Stock symbol: IMRX
Transactions as of: Aug 3, 2021
Transactions value $: $10,005
Form type: 4
Date filed: 8/4/2021, 06:04 AM
Previous filing: Jul 29, 2021
Next filing: Feb 14, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMRX	Class A Common Stock	Conversion of derivative security		+6K			6K	Aug 3, 2021	Direct	F1
transaction	IMRX	Class A Common Stock	Purchase	$10K	+667	+11.12%	$15.00	6.66K	Aug 3, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMRX	Series A Preferred Stock	Conversion of derivative security		-3.27K	-100%		0	Aug 3, 2021	Class A Common Stock	3.27K		Direct	F1
transaction	IMRX	Series B Preferred Stock	Conversion of derivative security		-2.72K	-100%		0	Aug 3, 2021	Class A Common Stock	2.72K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.